The pharmaceutical industry is undergoing significant transformation, marked by the growing integration of artificial intelligence (AI) and quantum computing in drug research and development (R&D). Sanofi, as a sector leader, continues to lead the way by integrating AI at every stage of its value chain. Concurrently, players like Google DeepMind and PsiQuantum are introducing radical innovations such as the AlphaGenome Atlas and the photon-based quantum computer, respectively. These advances promise to transform genomic research and drug development while posing significant regulatory and ethical challenges.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
